$ICUI
ICU Medical Inc

2013 Q1 Form 10-Q Financial Statement

#000088398413000023 Filed on April 22, 2013

View on sec.gov

Income Statement

Concept 2013 Q1 2012 Q3 2012 Q1
Revenue $74.30M $81.41M $75.51M
YoY Change -1.61% 6.47% 5.65%
Cost Of Revenue $37.51M $40.71M $40.55M
YoY Change -7.5% -0.43% 10.04%
Gross Profit $36.79M $40.70M $34.97M
YoY Change 5.23% 14.4% 0.98%
Gross Profit Margin 49.52% 49.99% 46.3%
Selling, General & Admin $22.87M $20.18M $20.89M
YoY Change 9.46% -1.15% -8.63%
% of Gross Profit 62.15% 49.58% 59.75%
Research & Development $1.903M $2.988M $2.693M
YoY Change -29.34% 59.19% 31.24%
% of Gross Profit 5.17% 7.34% 7.7%
Depreciation & Amortization $4.712M $4.800M $4.777M
YoY Change -1.36% 4.35% 6.16%
% of Gross Profit 12.81% 11.8% 13.66%
Operating Expenses $24.77M $23.17M $23.58M
YoY Change 5.03% 3.93% 5.21%
Operating Profit $12.03M $17.53M $11.38M
YoY Change 5.65% 31.94% -6.79%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $168.0K $158.0K $135.0K
YoY Change 24.44% 19.7% -66.5%
Pretax Income $12.19M $17.69M $11.52M
YoY Change 5.87% 31.82% -8.7%
Income Tax $3.508M $5.500M $3.916M
% Of Pretax Income 28.77% 31.09% 34.0%
Net Earnings $8.685M $12.19M $7.601M
YoY Change 14.26% 31.61% -5.85%
Net Earnings / Revenue 11.69% 14.97% 10.07%
Basic Earnings Per Share $0.60 $0.85 $0.54
Diluted Earnings Per Share $0.58 $0.82 $0.53
COMMON SHARES
Basic Shares Outstanding 14.51M shares 14.32M shares 13.96M shares
Diluted Shares Outstanding 15.05M shares 14.83M shares 14.32M shares

Balance Sheet

Concept 2013 Q1 2012 Q3 2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $233.6M $204.3M $183.6M
YoY Change 27.23% 71.54% 71.91%
Cash & Equivalents $154.6M $127.5M $122.1M
Short-Term Investments $78.90M $76.80M $61.50M
Other Short-Term Assets $10.80M $10.10M $9.700M
YoY Change 11.34% -24.06% -32.17%
Inventory $36.54M $37.59M $37.29M
Prepaid Expenses
Receivables $52.94M $53.01M $41.73M
Other Receivables $300.0K $7.600M $3.700M
Total Short-Term Assets $334.1M $312.6M $276.0M
YoY Change 21.06% 31.75% 23.76%
LONG-TERM ASSETS
Property, Plant & Equipment $86.99M $83.64M $83.18M
YoY Change 4.58% -3.55% -3.16%
Goodwill $1.478M $1.478M $1.478M
YoY Change 0.0% 0.0%
Intangibles $9.647M $10.42M $11.07M
YoY Change -12.82% -11.01%
Long-Term Investments
YoY Change
Other Assets $5.600M $4.800M $4.800M
YoY Change 16.67% -23.81% 4.35%
Total Long-Term Assets $103.8M $100.3M $100.5M
YoY Change 3.25% -5.59% -5.37%
TOTAL ASSETS
Total Short-Term Assets $334.1M $312.6M $276.0M
Total Long-Term Assets $103.8M $100.3M $100.5M
Total Assets $437.9M $412.9M $376.5M
YoY Change 16.31% 20.2% 14.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.04M $12.17M $11.83M
YoY Change -6.64% 8.53% -14.31%
Accrued Expenses $14.53M $16.75M $13.56M
YoY Change 7.12% 30.04% 6.79%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $25.57M $28.91M $25.39M
YoY Change 0.71% 20.03% -8.02%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.300M $3.800M $4.100M
YoY Change -19.51% -15.56% -2.38%
Total Long-Term Liabilities $3.300M $3.800M $4.100M
YoY Change -19.51% -15.56% -2.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $25.57M $28.91M $25.39M
Total Long-Term Liabilities $3.300M $3.800M $4.100M
Total Liabilities $34.40M $39.90M $36.60M
YoY Change -6.01% 9.02% -8.04%
SHAREHOLDERS EQUITY
Retained Earnings $350.8M $329.8M $308.5M
YoY Change 13.73% 15.47%
Common Stock $67.22M $63.74M $59.59M
YoY Change 12.8% 10.07%
Preferred Stock
YoY Change
Treasury Stock (at cost) $10.78M $17.01M $27.03M
YoY Change -60.12% -53.7%
Treasury Stock Shares 276.0K shares 738.0K shares
Shareholders Equity $403.5M $373.0M $339.9M
YoY Change
Total Liabilities & Shareholders Equity $437.9M $412.9M $376.5M
YoY Change 16.31% 20.2% 14.36%

Cashflow Statement

Concept 2013 Q1 2012 Q3 2012 Q1
OPERATING ACTIVITIES
Net Income $8.685M $12.19M $7.601M
YoY Change 14.26% 31.61% -5.85%
Depreciation, Depletion And Amortization $4.712M $4.800M $4.777M
YoY Change -1.36% 4.35% 6.16%
Cash From Operating Activities $10.76M $9.400M $18.34M
YoY Change -41.3% -11.32% 20.89%
INVESTING ACTIVITIES
Capital Expenditures $5.831M -$5.400M $3.632M
YoY Change 60.55% 35.0% -26.51%
Acquisitions
YoY Change
Other Investing Activities -$800.0K -$5.200M -$1.000M
YoY Change -20.0% -74.0% -95.28%
Cash From Investing Activities -$7.000M -$10.50M -$4.891M
YoY Change 43.12% -56.43% -81.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $5.205M 6.200M $8.391M
YoY Change -37.97% -193.94% 278.66%
NET CHANGE
Cash From Operating Activities $10.76M 9.400M $18.34M
Cash From Investing Activities -$7.000M -10.50M -$4.891M
Cash From Financing Activities $5.205M 6.200M $8.391M
Net Change In Cash $8.969M 5.100M $21.84M
YoY Change -58.93% -125.37% -348.56%
FREE CASH FLOW
Cash From Operating Activities $10.76M $9.400M $18.34M
Capital Expenditures $5.831M -$5.400M $3.632M
Free Cash Flow $4.933M $14.80M $14.70M
YoY Change -66.45% 1.37% 43.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
11308000 USD
CY2013Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
11040000 USD
CY2013Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
52943000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
49127000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17810000 USD
CY2013Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14527000 USD
CY2013Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
116209000 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
112836000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1429000 USD
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3799000 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
63770000 USD
CY2013Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
65736000 USD
CY2011Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
998000 USD
CY2012Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
824000 USD
CY2013Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
142000 shares
CY2012Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
141000 shares
CY2013Q1 us-gaap Assets
Assets
437882000 USD
CY2012Q4 us-gaap Assets
Assets
428512000 USD
CY2013Q1 us-gaap Assets Current
AssetsCurrent
334127000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
325503000 USD
CY2013Q1 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
78929000 USD
CY2012Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
79259000 USD
CY2013Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
196000 USD
CY2012Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
588000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
146900000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
154631000 USD
CY2011Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
122103000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
99590000 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
154631000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
22513000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
7731000 USD
CY2012Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
226159000 USD
CY2013Q1 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
233560000 USD
CY2013Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2012Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2012Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2012Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14855000 shares
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14855000 shares
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14458000 shares
CY2012Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14579000 shares
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
1486000 USD
CY2013Q1 us-gaap Common Stock Value
CommonStockValue
1486000 USD
CY2013Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
6315000 USD
CY2012Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
9688000 USD
CY2012Q4 us-gaap Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value
ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue
0 USD
CY2013Q1 us-gaap Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value
ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue
0 USD
CY2012Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
40546000 USD
CY2013Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
37505000 USD
CY2013Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
4788000 USD
CY2012Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
4293000 USD
CY2012Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
5642000 USD
CY2013Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
5636000 USD
CY2013Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
5539000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
5247000 USD
CY2012Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4777000 USD
CY2013Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4712000 USD
CY2013Q1 us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="font-family:Times New Roman;font-size:10pt;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ote 2:</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> New Accounting Pronouncements:</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"></font><font style="font-family:inherit;font-size:10pt;">In February 2013, the Financial Accounting Standards Board issued Accounting Standards Update ("ASU") number 2013-02, Other Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income to improve the reporting of reclassifications out of accumulated other comprehensive income. ASU 2013-02 requires reporting the effect of significant reclassifications out of accumulated other comprehensive income on the respective line items in net income. It is effective prospectively for fiscal years, and interim periods within those years, beginning after December 15, 2012. The adoption of this ASU does not affect our consolidated financial statements, but could require additional disclosure if applicable in future periods.</font></div></div>
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.60
CY2012Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.54
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
CY2012Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.53
CY2012Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
677000 USD
CY2013Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1238000 USD
CY2013Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.29
CY2012Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.34
CY2013Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1034000 USD
CY2012Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1626000 USD
CY2013Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2012Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-27000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
1478000 USD
CY2013Q1 us-gaap Goodwill
Goodwill
1478000 USD
CY2012Q1 us-gaap Gross Profit
GrossProfit
34965000 USD
CY2013Q1 us-gaap Gross Profit
GrossProfit
36794000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
12193000 USD
CY2012Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
11517000 USD
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3508000 USD
CY2012Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3916000 USD
CY2012Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1610000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-244000 USD
CY2012Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1931000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3981000 USD
CY2013Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2949000 USD
CY2012Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2608000 USD
CY2013Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
578000 USD
CY2012Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3768000 USD
CY2013Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1234000 USD
CY2012Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-898000 USD
CY2012Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
362000 shares
CY2013Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
546000 shares
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9952000 USD
CY2013Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9647000 USD
CY2012Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
12512000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
36333000 USD
CY2013Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
12471000 USD
CY2013Q1 us-gaap Inventory Net
InventoryNet
36540000 USD
CY2012Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
20808000 USD
CY2013Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
19616000 USD
CY2013Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
4453000 USD
CY2012Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
3013000 USD
CY2012Q1 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
357000 USD
CY2013Q1 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
675000 USD
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
437882000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
428512000 USD
CY2013Q1 us-gaap Liabilities Current
LiabilitiesCurrent
25567000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
29118000 USD
CY2012Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
3290000 USD
CY2013Q1 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
3290000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5205000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8391000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4891000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7000000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10764000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
18336000 USD
CY2012Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
135000 USD
CY2013Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
168000 USD
CY2012Q1 us-gaap Operating Expenses
OperatingExpenses
23583000 USD
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
24769000 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
12025000 USD
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
11382000 USD
CY2012Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2087000 USD
CY2013Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2370000 USD
CY2012Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-493000 USD
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-880000 USD
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
USD
CY2011Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
295000 USD
CY2012Q1 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
128000 USD
CY2013Q1 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
126000 USD
CY2013Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
355000 USD
CY2012Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
287000 USD
CY2012Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
22424000 USD
CY2013Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
19131000 USD
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5831000 USD
CY2012Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3632000 USD
CY2012Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2012Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2012Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2011Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2011Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6007000 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7271000 USD
CY2012Q4 us-gaap Prepaid Taxes
PrepaidTaxes
2320000 USD
CY2013Q1 us-gaap Prepaid Taxes
PrepaidTaxes
289000 USD
CY2012Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
21442000 USD
CY2013Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
18317000 USD
CY2012Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
10000 USD
CY2013Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2013Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2904000 USD
CY2012Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5684000 USD
CY2013Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1267000 USD
CY2012Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1081000 USD
CY2012Q1 us-gaap Profit Loss
ProfitLoss
7601000 USD
CY2013Q1 us-gaap Profit Loss
ProfitLoss
8685000 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
198773000 USD
CY2013Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
203203000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
85937000 USD
CY2013Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
86994000 USD
CY2012Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-263000 USD
CY2013Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-191000 USD
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1903000 USD
CY2012Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2693000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
342158000 USD
CY2013Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
350843000 USD
CY2013Q1 us-gaap Revenues
Revenues
74299000 USD
CY2012Q1 us-gaap Revenues
Revenues
75511000 USD
CY2013Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
74173000 USD
CY2012Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
75383000 USD
CY2012Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
20890000 USD
CY2013Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
22866000 USD
CY2012Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1231000 USD
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1390000 USD
CY2013Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
403486000 USD
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
390857000 USD
CY2012Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
276000 shares
CY2011Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
397000 shares
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
15128000 USD
CY2013Q1 us-gaap Treasury Stock Value
TreasuryStockValue
10780000 USD
CY2012Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14318000 shares
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15053000 shares
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14507000 shares
CY2012Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13956000 shares
CY2013Q1 icui Debt Securities Maturity Date Range High
DebtSecuritiesMaturityDateRangeHigh
2042
CY2013Q1 icui Debt Securities Maturity Date Range Low
DebtSecuritiesMaturityDateRangeLow
2013
CY2012Q1 icui Increase Decrease In Prepaid And Deferred Income Taxes
IncreaseDecreaseInPrepaidAndDeferredIncomeTaxes
1915000 USD
CY2013Q1 icui Increase Decrease In Prepaid And Deferred Income Taxes
IncreaseDecreaseInPrepaidAndDeferredIncomeTaxes
2017000 USD
CY2012Q1 icui Provision For Warranty And Returns
ProvisionForWarrantyAndReturns
312000 USD
CY2013Q1 icui Provision For Warranty And Returns
ProvisionForWarrantyAndReturns
-6000 USD
CY2013Q1 dei Amendment Flag
AmendmentFlag
false
CY2013Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2013Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013Q1 dei Document Period End Date
DocumentPeriodEndDate
2013-03-31
CY2013Q1 dei Document Type
DocumentType
10-Q
CY2013Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000883984
CY2013Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14579436 shares
CY2013Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2013Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2013Q1 dei Entity Registrant Name
EntityRegistrantName
ICU MEDICAL INC/DE

Files In Submission

Name View Source Status
0000883984-13-000023-index-headers.html Edgar Link pending
0000883984-13-000023-index.html Edgar Link pending
0000883984-13-000023.txt Edgar Link pending
0000883984-13-000023-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
icui-20130331.xml Edgar Link completed
icui-20130331.xsd Edgar Link pending
icui-20130331_cal.xml Edgar Link unprocessable
icui-20130331_def.xml Edgar Link unprocessable
icui-20130331_lab.xml Edgar Link unprocessable
icui-20130331_pre.xml Edgar Link unprocessable
icui-ex311_20130331x10q.htm Edgar Link pending
icui-ex312_20130331x10xq.htm Edgar Link pending
icui-ex321_20130331x10xq.htm Edgar Link pending
icui03311310-q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending